Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes

被引：0
|
作者：
Jinsong Geng
Hao Yu
Yiwei Mao
Peng Zhang
Yingyao Chen
机构：
[1] Fudan University,National Key Laboratory of Health Technology Assessment (Ministry of Health), Collaborative Innovation Center of Social Risks Governance in Health, School of Public Health
[2] RAND Corporation,undefined
来源：
PharmacoEconomics | 2015年 / 33卷
关键词：
Metformin; Economic Evaluation; Rosiglitazone; Pioglitazone; Sulfonylurea;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：581 / 597
页数：16
相关论文
共 50 条
  • [1] Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
    Geng, Jinsong
    Yu, Hao
    Mao, Yiwei
    Zhang, Peng
    Chen, Yingyao
    [J]. PHARMACOECONOMICS, 2015, 33 (06) : 581 - 597
  • [2] The Efficacy, Safety, and Cost Effectiveness Evaluation of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes
    Feng, Yufei
    Li, Ting
    Xu, Lei
    Sun, Xuelin
    Hu, Xin
    [J]. DIABETES, 2017, 66 : A635 - A635
  • [3] Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes
    Scheen, Andre J.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (04) : 505 - 524
  • [4] Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
    Mkele, Gail
    [J]. JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2015, 20 (01) : 64 - 66
  • [5] Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
    Jang, Yun-Mi
    Kim, Dong-Lim
    [J]. DIABETES & METABOLISM JOURNAL, 2011, 35 (02) : 117 - 118
  • [6] Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus
    Neumiller, Joshua J.
    Wood, Lindy
    Campbell, R. Keith
    [J]. PHARMACOTHERAPY, 2010, 30 (05): : 463 - 484
  • [7] Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
    Mkele, Gail
    [J]. SOUTH AFRICAN FAMILY PRACTICE, 2013, 55 (06) : 508 - 510
  • [8] Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
    Mkele, Gail
    [J]. SA PHARMACEUTICAL JOURNAL, 2013, 80 (02) : 17 - 19
  • [9] Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: Focus on sitagliptin
    Herman, G. A.
    Stein, P. P.
    Thornberry, N. A.
    Wagner, J. A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (05) : 761 - 767
  • [10] Dipeptidyl Peptidase-4 Inhibitors in Diverse Patient Populations With Type 2 Diabetes
    Hinnen, Deborah
    [J]. DIABETES EDUCATOR, 2015, 41 : 19S - 31S
12345